Estimación de riesgo cardiovascular ateroesclerótico en pacientes adultos sin sospecha de cifras tensionales elevadas

Estimation of aterosclerotic cardiovascular risk in adult patients without a suspicion of having high pressure readings

Estimativa do risco cardiovascular aterosclerótico em pacientes adultos sem suspeita de níveis elevados de tensão arterial

  • Fabiola Ivette García Castillo Clínica de Medicina Familiar Marina Nacional. Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado (ISSSTE)1 (Ciudad de México, México)
  • Metzli Yolotzin López Carrillo Clínica de Medicina Familiar Ermita. Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado (ISSSTE) (Ciudad de México, México)
  • Indira Mendiola-Pastrana Hospital General de Zona con Medicina Familiar No.8 (Ciudad de México, México)
  • Eduardo López Ortiz Facultad de Medicina. Universidad Nacional Autónoma de México (Ciudad de México, México)
  • Diana Guízar-Sánchez Facultad de Medicina. Universidad Nacional Autónoma de México (Ciudad de México, México)
  • Geovani López-Ortiz Facultad de Medicina. Universidad Nacional Autónoma de México (Ciudad de México, México)
Palabras clave: Factores de riesgo de enfermedad cardiaca, Hipertensión, Enfermedad cardiovascular, Factores de riesgo, Comorbilidad, México
Key-words: Heart disease risk factors, Hypertension, Cardiovascular disease, Risk factors, Comorbidity, Mexico
Palavras chave: Fatores de risco de doenças cardíacas, Hipertensão, Doença cardiovascular, Fatores de risco, Comorbidade, México

Resumen

Abstract

Resumo

Bibliografía

1. Gómez LA. Las enfermedades cardiovasculares: un problema de salud pública y un reto global. Biomédica. 2011; 31(4): 469-73. https://bit.ly/3kk7xdB
2. OMS. Enfermedades cardiovasculares. Ginebra: OMS; 2017. https://bit.ly/39g7vwN
3. Kunstmann S, Gainza F. Herramientas para la estimación del riesgo cardiovascular. Rev. méd. Clín. Las Condes. 2018; 29(1): 6-11. https://doi.org/10.1016/j.rmclc.2017.11.010
4. Andrade-Castellanos CA. Hipertensión arterial primaria: tratamiento farmacológico basado en la evidencia. Med Int Méx. 2015; 31: 191-5. https://bit.ly/39lazHU
5. Secretaría de Salud. Guía de Práctica Clínica. Diagnóstico y tratamiento de dislipidemias (hipercolesterolemia) en el adulto. México: CENETEC; Actualización 2016. https://bit.ly/3hQl1Md
6. Arnett DK, Blumenthal RS, Albert MA, Buroker AB, Goldberger ZD, Hahn EJ, et al. 2019 ACC/AHA Guideline on the primary prevention of cardiovascular disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019; 140(11): 596-646. https://doi.org/10.1161/CIR.0000000000000678
7. American Heart Association. Know your risk factors for high blood pressure. Dallas: AHA; 2020. https://bit.ly/2Xv3D8z
8. Forouzanfar MH, Liu P, Roth GA, Ng M, Biryukov S, Marczak L, et al. Global burden of hypertension and systolic blood pressure of at least 110 to 115 mm Hg, 1990-2015. JAMA. 2017; 317(2): 165-82. https://doi.org/10.1001/jama.2016.19043
9. World Health Organization. The top 10 causes of death. Ginebra: WHO; 2020. https://bit.ly/2Xtsr0K
10. Instituto Nacional de Salud Pública. Encuesta Nacional de Salud y Nutrición 2018. Presentación de resultados. México: INEGI/INSP/SSA; 2020. https://bit.ly/3krAy7e
11. Valenzuela-Flores AA, Solórzano-Santos F, Valenzuela-Flores AG, Durán-Arenas LG, Ponce de León-Rosales SP, Oropeza-Martínez MP, et al. Key recommendations of the clinical guidelines of arterial hypertension in primary care. Rev Med Inst Mex Seguro Soc. 2016; 54(2): 249-60. https://bit.ly/3u3isLN
12. Himmelfarb CRD, Commodore-Mensah Y, Hill MN. Expanding the role of nurses to improve hypertension care and control globally. Ann Glob Health. 2016; 82(2): 243-53. https://doi.org/10.1016/j.aogh.2016.02.003
13. Spies LA, Bader SG, Opollo JG, Gray J. Nurse-led interventions for hypertension: A scoping review with implications for evidence-based practice. Worldviews Evid Based Nurs. 2018; 15(4): 247-56. https://doi.org/10.1111/wvn.12297
14. Spies LA, Nanyonga RC, Nakaggwa F. Nurse-led interventions in the interim: Waiting on universal health coverage. Int Nurs Rev. 2019; 66(4): 549-52. https://doi.org/10.1111/inr.12558
15. Taler SJ. Initial treatment of hypertension. N Engl J Med. 2018; 378(7): 636-44. https://doi.org/10.1056/NEJMcp1613481
16. Whelton PK, Carey RM, Aronow WS, Casey DE, Collins KJ, Dennison Himmelfarb C, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension 2018; 71(6): 1269-324. https://doi.org/10.1161/HYP.0000000000000066
17. Bress AP, Colantonio LD, Cooper RS, Kramer H, Booth JN, Odden MC, et al. Potential cardiovascular disease events prevented with adoption of the 2017 American College of Cardiology/American Heart Association blood pressure guideline. Circulation. 2019; 139(1): 24-36. https://doi.org/10.1161/CIRCULATIONAHA.118.035640
18. Universidad Nacional Autónoma de México. Los médicos familiares, pilar de la salud. Gaceta Facultad de Medicina. 2018; 9(251): 1-16. https://bit.ly/39tq40t
19. León E, Tranche S, Montano J. Impacto económico de la medicina familiar en los sistemas de salud de Iberoamérica. Rev Bras Med Fam Comunidade. 2018; 13(Suppl 1): 43-53. https://doi.org/10.5712/rbmfc13(1)1852
20. Institute for Health Metrics and Evaluation. GBD Compare|Viz Hub. Seattle: University of Washington; 2020.
21. Gijón-Conde T, Gorostidi M, Camafort M, Abad-Cardiel M, Martín-Rioboo E, Morales-Olivas F, et al. Documento de la Sociedad Española de Hipertensión-Liga Española para la lucha contra la hipertensión arterial (SEH-LELHA) sobre las guías ACC/AHA 2017 de hipertensión arterial. Hipertens Riesgo Vasc. 2018; 35(3): 119-29. https://doi.org/10.1016/j.hipert.2018.04.001
22. Amercian College of Cardiology. ASCVD Risk Estimator Plus. Washington, D.C.: ACC; s/f. https://bit.ly/2XyIsCq
23. Wilson PWF, Kannel WB. Obesity, diabetes, and risk of cardiovascular disease in the elderly. Am J Geriatr Cardiol. 2002; 11(2): 119-24. https://doi.org/10.1111/j.1076-7460.2002.00998.x
24. Joseph JJ, Golden SH. Type 2 diabetes and cardiovascular disease: What next? Curr Opin Endocrinol Diabetes Obes. 2014; 21(2): 109-20. https://doi.org/10.1097/MED.0000000000000044
25. Merino J, Jablonski KA, Mercader JM, Kahn SE, Chen L, Harden M, et al. Interaction between type 2 diabetes prevention strategies and genetic determinants of coronary artery disease on cardiometabolic risk factors. Diabetes. 2020; 69(1): 112–20. https://doi.org/10.2337/db19-0097
26. Secretaría de Salud/Instituto Nacional de Salud Pública. Encuesta Nacional de Salud y Nutrición de Medio Camino 2016 (ENSANUT MC 2016). Informe final de resultados. México: SSA/INSP; 2016. https://bit.ly/3hW6XRo
27. Hinton TC, Adams ZH, Baker RP, Hope KA, Paton JFR, Hart EC, et al. Investigation and treatment of high blood pressure in young people: Too much medicine or appropriate risk reduction? Hypertension. 2020; 75(1): 16-22. https://doi.org/10.1161/HYPERTENSIONAHA.119.13820
28. Packer M. Heart Failure: The most important, preventable, and treatable cardiovascular complication of type 2 diabetes. Diabetes Care. 2018; 41(1): 11-3. https://doi.org/10.2337/dci17-0052
29. Adiukwu F, Ofori S, Ugbomah L. Vascular cognitive impairment, a cardiovascular complication. World J Psychiatry. 2016; 6(2): 199-207. https://doi.org/10.5498/wjp.v6.i2.199
30. Hisni D, Rukmaini R, Saryono S, Chinnawong T, Thaniwattananon P. Cardiovascular self-management support program for preventing cardiovascular complication behaviors and clinical outcomes in the elderly with poorly controlled type 2 diabetes mellitus in Indonesia: A pilot study. Jpn J Nurs Sci. 2019; 16(1): 25-36. https://doi.org/10.1111/jjns.12208
31. Wenger NK. Female-friendly focus: 2019 ACC/AHA Guideline on the primary prevention of cardiovascular disease. Clin Cardiol. 2019; 42(8): 706-9. https://doi.org/10.1002/clc.23218
32. Wu P, Haththotuwa R, Kwok CS, Babu A, Kotronias RA, Rushton C, et al. Preeclampsia and future cardiovascular health: A systematic review and meta-analysis. Circ Cardiovasc Qual Outcomes. 2017; 10(2): 1-9. https://doi.org/10.1161/CIRCOUTCOMES.116.003497
33. Woodward M. Cardiovascular disease and the female disadvantage. Int. J. Environ. Res. Public Health. 2019; 16(7): 1165.
34. Regitz-Zagrosek V. Sex and gender differences in health: Science & society series on sex and science. EMBO Rep. 2012; 13(7): 596-603. https://doi.org/10.1038/embor.2012.87
35. Mills KT, Stefanescu A, He J. The global epidemiology of hypertension. Nat Rev Nephrol. 2020; 16(4): 223-37. https://doi.org/10.1038/s41581-019-0244-2
36. Yano Y, Reis JP, Colangelo LA, Shimbo D, Viera AJ, Allen NB, et al. Association of blood pressure classification in young adults using the 2017 American College of Cardiology/American Heart Association blood pressure Guideline with cardiovascular events later in life. JAMA. 2018; 320(17): 1774-82. https://doi.org/10.1001/jama.2018.13551
37. Noubiap JJ, Bigna JJ, Nansseu JR, Nyaga UF, Balti EV, Echouffo-Tcheugui JB, et al. Prevalence of dyslipidaemia among adults in Africa: A systematic review and meta-analysis. Lancet Global Health. 2018; 6(9): e998-e1007. https://doi.org/10.1016/S2214-109X(18)30275-4
38. Harris MA, Ferguson TS, Boyne MS, Figueroa JP. High prevalence of dyslipidemia among primary care patients with hypertension and diabetes in Jamaica. Arch Med Sci Atheroscler Dis. 2017; 2: 61-7. https://doi.org/10.5114/amsad.2017.70596
39. American Diabetes Association. 10. Cardiovascular disease and risk management: Standards of medical care in diabetes-2020. Diabetes Care. 2020; 43(Suppl. 1): S111–34. https://doi.org/10.2337/dc20-s010
40. Lloyd-Jones DM, Braun LT, Ndumele CE, Smith SC, Sperling LS, Virani SS, et al. Use of risk assessment tools to guide decision-making in the primary prevention of atherosclerotic cardiovascular disease. J Am Coll Cardiol. 2019; 73(24): 3153-67. https://doi.org/10.1016/j.jacc.2018.11.005
41. Sarre-Álvarez D, Cabrera-Jardines R, Rodríguez-Weber F, Díaz-Greene E. Enfermedad cardiovascular aterosclerótica. Revisión de las escalas de riesgo y edad cardiovascular. Med. inter Méx. 2018; 34(6): 910-23. https://bit.ly/3cZgRim
42. Ahuja R, Ayala C, Tong X, Wall HK, Fang J. Public awareness of health-related risks from uncontrolled hypertension. Prev Chronic Dis. 2018; 15: 1-9. https://doi.org/10.5888/pcd15.170362
43. Thomas C, Brennan A, Goka E, Squires HY, Brenner G, Bagguley D, et al. What are the cost-savings and health benefits of improving detection and management for six high cardiovascular risk conditions in England? An economic evaluation. BMJ Open. 2020; 10(9): 2-10. https://doi.org/10.1136/bmjopen-2020-03748
44. Basu S, Wagner RG, Sewpaul R, Reddy P, Davies J. Implications of scaling up cardiovascular disease treatment in South Africa: A microsimulation and cost-effectiveness analysis. Lancet Glob Health. 2019; 7(2): e270-80. https://doi.org/10.1016/S2214-109X(18)30450-9
45. Heintzman JD, Bailey SR, Muench J, Killerby M, Cowburn S, Marino M. Lack of lipid screening disparities in obese latino adults at health centers. Am J Prev Med. 2017; 52(6): 805-9. https://doi.org/10.1016/j.amepre.2016.12.020
46. Mattiuzzi C, Sanchis-Gomar F, Lippi G. Worldwide burden of LDL cholesterol: Implications in cardiovascular disease. Nutr Metab Cardiovasc Dis. 2020; 30(2): 241-4. https://doi.org/10.1016/j.numecd.2019.09.008
47. Escortell-Mayor E, Del Cura-González I, Ojeda-Ruiz E, Sanz-Cuesta T, Rodríguez-Salceda I, García-Soltero J, et al. A primary healthcare information intervention for communicating cardiovascular risk to patients with poorly controlled hypertension: The Education and Coronary Risk Evaluation (Educore) study-A pragmatic, cluster-randomized trial. PLoS ONE. 2020; 15(1): 1-17. https://doi.org/10.1371/journal.pone.0226398

Novedades
Estadísticas
Cómo citar
1.
García Castillo, Fabiola Ivette; López Carrillo, Metzli Yolotzin; Mendiola-Pastrana, Indira; López Ortiz, Eduardo; Guízar-Sánchez, Diana; López-Ortiz, Geovani. Estimación de riesgo cardiovascular ateroesclerótico en pacientes adultos sin sospecha de cifras tensionales elevadas. Enfermería Universitaria. 2021; 18(2): 48-2. Disponible en: http://ciberindex.com/c/reu/4828reu [acceso: 06/10/2022]
Sección
Artículos de investigación
Comentarios

DEJA TU COMENTARIO     VER 0 COMENTARIOS

Normas y uso de comentarios


Hay un total de 0 comentarios


INTRODUCIR NUEVO COMENTARIO

Para enviar un comentario, rellene los campos situados debajo. Recuerde que es obligatorio indicar un nombre y un email para enviar su comentario (el email no sera visible en el comentario).

Nombre:
e-mail:
Comentario: